Hypothesis: Non-small cell lung cancer (NSCLC) is characterized by a multitude of genetic aberrations with unknown clinical impact. In this study, we aimed to identify gene copy number changes that co

NIAID Data Ecosystem70

Overview of the 9 genes showing consistent association with both PFS and OS (n = 51 patients with nsNSCLC).

肺癌基因研究

癌症预后生物标志物

Abbreviations: ADC, adenocarcinoma; IL, interleukin, LSCLC, large-cell lung cancer; mRNA, messenger ribonucleic acid; nsNSCLC, non-squamous non-small cell lung cancer; SCLC, small-cell lung cancer; SP

NIAID Data Ecosystem40

Additional file 6 of Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort

肺癌基因研究

临床病理特征

Supplementary Table 2: Relationship between top 30 gene mutations and clinicopathological features.

Figshare2023-06-10 更新40

Table S2 from Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer

癌症免疫治疗响应预测

肺癌基因研究

Individual gene mutations correlate with immunotherapy response in both Rizvi et al and our data

NIAID Data Ecosystem50

Additional file 7 of ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer